Junfeng Wang, MD
Medical Oncologist
Laryngeal Cancer Lung Cancer Ovarian Cancer Pericardial Mesothelioma Peritoneal Mesothelioma Pleural Mesothelioma Testicular Mesothelioma
Biological Therapy/Immunotherapy Chemotherapy Gene Therapy Pain Management Photodynamic Therapy Targeted Therapy
West China University of Medical Sciences
Medical School
Greenwich Hospital
Residency
University of Washington
Fellowship
American Board of Internal Medicine - Oncology
TN State Medical License: 2014 - 2018
UT State Medical License: 2012 - 2018
WA State Medical License: 2008 - 2018
American Board of Internal Medicine: Internal Medicine
American Board of Internal Medicine: Medical Oncology
American Board of Internal Medicine: Hematology
Inferring clonal composition from multiple sections of a breast cancer.
Zare, H.,Wang, J.,Hu, A.,Weber, K.,Smith, J.,Nickerson, D.,Song, C.,Witten, D.,Blau, C. A.,Noble, W. S.; PLoS Comput. Biol.. 2014 Jul 11.
See more >>Nonresponse to Neoadjuvant Chemotherapy for Muscle-Invasive Urothelial Cell Carcinoma of the Bladder.
Mossanen, M.,Lee, F.,Cheng, H.,Harris, W.,Shenoi, J.,Zhao, S.,Wang, J.,Champion, T.,Izard, J.,Gore, J. L.,Porter, M. P.,Yu, E. Y.,Wright, J. L.; Clin Genitourin Cancer. 2013 Dec 24.
See more >>Pathologic Response Rates of Gemcitabine/Cisplatin versus Methotrexate/Vinblastine/Adriamycin/Cisplatin Neoadjuvant Chemotherapy for Muscle Invasive Urothelial Bladder...
Lee, F. C.,Harris, W.,Cheng, H. H.,Shenoi, J.,Zhao, S.,Wang, J.,Champion, T.,Izard, J.,Gore, J. L.,Porter, M.,Yu, E. Y.,Wright, J. L.; Adv Urol. 2014 Jan 03.
See more >>